[HTML][HTML] Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis

X Su, Y Gao, R Yang - Cells, 2022 - mdpi.com
Tryptophan is an essential amino acid from dietary proteins. It can be metabolized into
different metabolites in both the gut microbiota and tissue cells. Tryptophan metabolites such …

[HTML][HTML] Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer

L Zhao, Y Liu, S Zhang, L Wei, H Cheng, J Wang… - Cell death & …, 2022 - nature.com
Metabolic disorders and abnormal immune function changes occur in tumor tissues and
cells to varying degrees. There is increasing evidence that reprogrammed energy …

Colorectal cancer: Metabolic interactions reshape the tumor microenvironment

J Chen, H Zhu, Y Yin, S Jia, X Luo - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Colorectal cancer (CRC) is one of the most common cancers worldwide, which ranks third in
terms of incidence and the second leading cause of cancer-related mortality. Metabolic …

[HTML][HTML] Pretreated mesenchymal stem cells and their secretome: enhanced immunotherapeutic strategies

Y Su, C Xu, W Cheng, Y Zhao, L Sui… - International journal of …, 2023 - mdpi.com
Mesenchymal stem cells (MSCs) with self-renewing, multilineage differentiation and
immunomodulatory properties, have been extensively studied in the field of regenerative …

[HTML][HTML] Indoleamine 2, 3-dioxygenase 1: a promising therapeutic target in malignant tumor

X Song, Q Si, R Qi, W Liu, M Li, M Guo, L Wei… - Frontiers in …, 2021 - frontiersin.org
Tumorigenesis is a complex multifactorial and multistep process in which tumors can utilize
a diverse repertoire of immunosuppressive mechanisms to evade host immune attacks. The …

[HTML][HTML] Mechanism and strategies of immunotherapy resistance in colorectal cancer

J Shan, D Han, C Shen, Q Lei, Y Zhang - Frontiers in immunology, 2022 - frontiersin.org
Colorectal cancer (CRC) is the third most common cancer in the world. Although there are
standard treatment options for CRC, most patients respond poorly to these treatments …

Comprehensive metabolic profiling and genome-wide analysis reveal therapeutic modalities for hepatocellular carcinoma

F Qi, J Li, Z Qi, J Zhang, B Zhou, B Yang, W Qin, W Cui… - Research, 2023 - spj.science.org
Understanding the details of metabolic reprogramming in hepatocellular carcinoma (HCC) is
critical to improve stratification for therapy. Both multiomics analysis and cross-cohort …

[HTML][HTML] Glioblastoma therapy: past, present and future

E Obrador, P Moreno-Murciano… - International journal of …, 2024 - mdpi.com
Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

[HTML][HTML] Abnormal tryptophan catabolism in diabetes mellitus and its complications: opportunities and challenges

J Gao, T Yang, B Song, X Ma, Y Ma, X Lin… - Biomedicine & …, 2023 - Elsevier
In recent years, the incidence rate of diabetes mellitus (DM), including type 1 diabetes
mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM) …

[HTML][HTML] Indole metabolites and colorectal cancer: gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms

Y Liu, Z Pei, T Pan, H Wang, W Chen, W Lu - Microbiological Research, 2023 - Elsevier
Tryptophan (Trp) functions in host-disease interactions. Its metabolism is a multi-pathway
process. Indole and its derivatives are Trp metabolites unique to the human gut microbiota …